Evidence map›Paper›PMID 40595822›Full record

ArticleScientific reports2025

Predictive quality of census-based socio-economic indicators on Covid-19 infection risk at a fine spatial scale in France.

Nicolas Romain-Scelle, Benjamin Riche, Thomas Benet, Muriel Rabilloud

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nicolas Romain-ScelleUniversité Lyon 1, Lyon, France. nicolas.romain-scelle@chu-lyon.fr.ORCID http://orcid.org/0000-0002-9036-411X
Benjamin RicheService de Biostatistiques-Bioinformatique, Hospices Civils de Lyon, Lyon, France.
Thomas BenetAuvergne-Rhône-Alpes Regional Office, Santé Publique France, Lyon, France.
Muriel RabilloudUniversité Lyon 1, Lyon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic in France induced the development of a national, high spatiotemporal resolution confirmed infection cases database. We aimed to estimate the predictive ability of census-based indicators on the infection risk to assess their potential usefulness in future pandemic response. We collected and aggregated all counts of biologically confirmed cases of SARS-CoV-2 infection in the Auvergne-Rhône-Alpes region in France at small-area statistical units between May 2020 and February 2021 (second wave). Ten census-based ecological covariates were evaluated as predictors of case incidence using a Poisson regression with conditional autoregressive (CAR) spatial effects. Benefits of CAR effects and covariates on model predictive ability was assessed comparing posterior predictive distribution of case incidence with the observed value for each statistical unit. Among 7,917,997 inhabitants, 438,992 infection cases over 5410 neighbourhoods were analysed. Spatial correlation was high for the periods before and after the epidemic peak, and illustrated with cartography. The addition of covariates to the null model led to an increase in satisfying prediction of + 5% from 14%, with a maximum of 21% across all periods. The ecological covariates assessed were insufficient to provide a satisfying prediction of infection risk without explicitly accounting for the spatial organization of the epidemic.

Indexed as

CensusesCOVID-19FranceHumansIncidenceMalePandemicsRisk FactorsSARS-CoV-2Socioeconomic FactorsEmerging diseasesEpidemiologyModellingSARS-CoV-2Spatial statistics

Identifiers

PMID40595822
PMCPMC12214651

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.